Compare USBC & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | USBC | PMI |
|---|---|---|
| Founded | N/A | 1981 |
| Country | | United States |
| Employees | 24 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.2M | 202.7M |
| IPO Year | N/A | N/A |
| Metric | USBC | PMI |
|---|---|---|
| Price | $0.36 | $1.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 435.9K | ★ 1.6M |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.38 | $1.13 |
| 52 Week High | $1.97 | $13.68 |
| Indicator | USBC | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 32.41 | 26.57 |
| Support Level | N/A | N/A |
| Resistance Level | $0.53 | $2.45 |
| Average True Range (ATR) | 0.04 | 0.20 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 4.84 | 0.22 |
USBC Inc is a multi-disciplinary technology company that is an innovator in digital financial technologies. The company develops financial services including digital assets and banking solutions, as well as non-invasive health monitoring research. USBC has implemented a Bitcoin treasury strategy to support development and research across its various divisions. A key focus is the further development of its tokenized deposit program, a tokenized representation of a U.S.-dollar-denominated bank deposit account that operates on blockchain technology and is embedded with digital identity, alongside its legacy non-invasive sensor technology business, with the objective of creating long-term shareholder value in an evolving financial landscape.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.